Sessions & Tracks
Overview
The Global Summit on Cancer Advances (GSCA 2026), hosted by ResearchRISER.org, offers a transformative program of tracks and sessions that push the boundaries of cancer research and care. Held in a hybrid format in San Francisco and online from September 16-18, 2026, these sessions connect global experts, clinicians, and innovators to Elevate Knowledge, Connect Globally. Explore the diverse tracks below, each designed to inspire collaboration and address pressing oncology challenges.
Cancer Biology & Genomics
Focus: Exploring the molecular and genomic foundations of cancer.
- Tumor Microenvironment & Metastasis
- Genomic Profiling & Mutational Landscapes
- Cancer Stem Cells & Signaling Pathways
- Molecular Mechanisms of Resistance
Target Audience: Researchers, geneticists, oncologists.
Immuno-Oncology & Cancer Vaccines
Focus: Harnessing the immune system to combat cancer.
- CAR-T Cell Therapy
- Immune Checkpoint Inhibitors
- Tumor-Infiltrating Lymphocytes (TILs)
- Neoantigen Vaccines & mRNA Technology
Target Audience: Immunologists, oncologists, vaccine developers.
Clinical Oncology & Therapeutics
Focus: Advancing patient care through innovative treatments.
- Advancements in Chemotherapy & Radiotherapy
- Personalized Medicine in Oncology
- Multimodal Cancer Therapy Approaches
- Management of Treatment-Related Toxicity
Target Audience: Clinicians, oncologists, therapists.
Translational Research & Drug Development
Focus: Bridging lab discoveries to clinical applications.
- Preclinical Cancer Models
- AI/ML in Drug Discovery
- Combination Therapies
- Clinical Trials: Phase I–III Updates
Target Audience: Researchers, pharmacologists, clinical trial specialists.
Neurological & Brain Cancers
Focus: Innovations in brain cancer research and treatment.
- Glioblastoma and Astrocytoma Innovations
- Blood–Brain Barrier Drug Delivery
- Pediatric Neuro-Oncology
- Neuroimaging Biomarkers
Target Audience: Neuro-oncologists, pediatric oncologists, radiologists.
Rare Cancers & Orphan Tumors
Focus: Addressing unique challenges in rare cancer care.
- Sarcomas and Rare Solid Tumors
- Rare Blood Malignancies
- Genetic Syndromes Linked to Rare Cancers
- Global Registries and Patient Advocacy
Target Audience: Rare disease experts, oncologists, patient advocates.
Global Oncology & Disparities
Focus: Tackling global cancer care inequities.
- Cancer Care in LMICs
- Disparities in Cancer Screening and Outcomes
- Global Cancer Burden and Strategies
- WHO/UN Initiatives and Policy Frameworks
Target Audience: Public health experts, policymakers, global health advocates.
Nursing, Palliative, & Psychosocial Oncology
Focus: Enhancing patient support Holistic care in oncology.
- Cancer Pain Management & Palliative Interventions
- Oncology Nursing Practices & Burnout
- Psychosocial Support & Survivorship
- Ethical Dilemmas in End-of-Life Care
Target Audience: Nurses, palliative care specialists, psychologists.
Liquid Biopsy, Biomarkers & Early Detection
Focus: Advancing early detection through innovative diagnostics.
- ctDNA and Circulating Tumor Cells
- Predictive & Prognostic Markers
- Multi-Cancer Early Detection (MCED) Tests
- Point-of-Care Diagnostics
Target Audience: Diagnostic specialists, oncologists, researchers.
Artificial Intelligence & Digital Oncology
Focus: Leveraging technology for oncology advancements.
- AI for Imaging and Pathology
- Predictive Modeling & Prognosis Tools
- Digital Therapeutics & Remote Monitoring
- Blockchain in Health Data Management
Target Audience: Technologists, data scientists, healthcare innovators.
Precision Oncology & Personalized Treatment
Focus: Tailoring treatments to individual patients.
- Targeted Therapies (e.g., PARP, BRAF, KRAS Inhibitors)
- NGS-Guided Treatment Algorithms
- Liquid Biopsy-Driven Therapy Adjustment
- Tumor Boards and AI-Assisted Decisions
Target Audience: Oncologists, geneticists, clinical researchers.
Lifestyle, Nutrition & Cancer Prevention
Focus: Reducing cancer risk through proactive measures.
- Cancer Epidemiology & Prevention Strategies
- Diet, Microbiome & Cancer Interaction
- Smoking Cessation and HPV Vaccination
- Environmental Carcinogens & Policies
Target Audience: Public health experts, nutritionists, policymakers.
Stay Informed: Program Overview | Contact Us